Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - IMMAGE BIOTHERAPEUTICS CORP. | 2016feb29-immg_10q.htm |
| EX-31.1 - EX 31.1 - IMMAGE BIOTHERAPEUTICS CORP. | ex-31_1.htm |
| EX-31.2 - EX 31.2 - IMMAGE BIOTHERAPEUTICS CORP. | ex-31_2.htm |
| EX-32.2 - EX 32.2 - IMMAGE BIOTHERAPEUTICS CORP. | ex-32_2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q for the period ended February 29, 2016 of Immage Biotherapeutics Corp., a Nevada corporation (the "Company"), as filed with the Securities and Exchange Commission on the date hereof (the "Transition Report"), I, Zhi Cong Mou, President of the Company certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Quarterly Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of 1934, as amended; and
2. The information contained in this Quarterly Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
/s/ Zhi Cong Mou
Zhi Cong Mou
President, Secretary Treasurer,
Principal Executive Officer, and
Director
Date: April 14, 2016